ESC 365 - Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

ESC Professional Premium Access

Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

Session: Cardiac amyloidosis: my heart is filled with so much…

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Zampieri (Florence, IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Mattia Zampieri

Careggi University Hospital (AOUC), Florence (Italy)

0 follower

4 more presentations in this session

Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records

Speaker: Doctor L. Anderson (London, GB)

Usefulness of scintigraphy with [99mTc]Tc-DPD for the detection of transthyretin cardiac amyloidosis. Reference centre experience in an endemic area.

Speaker: Doctor N. Orta (Palma de Mallorca, ES)

Cardiac magnetic resonance T1 imaging for the diagnosis of cardiac amyloidosis among patients with symptomatic heart failure

Speaker: Doctor R. Gessner (Leipzig, DE)

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis

Speaker: Mr S. Muller (Utrecht, NL)

Access the full session

Cardiac amyloidosis: my heart is filled with so much…

Speakers: Doctor M. Zampieri, Doctor L. Anderson, Doctor N. Orta, Doctor R. Gessner, Mr S. Muller

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources